WALTHAM, Mass.--(BUSINESS WIRE)--Fresenius Medical Care North America (“FMCNA”), wholly-owned subsidiary of Fresenius Medical Care AG & Co. KGaA (“FMC”) (Frankfurt Stock Exchange; FME and NYSE: FMS), will introduce the Liberty™ Cycler during the 28th Annual Dialysis Conference, Orlando, Florida, March 1-4, 2008. This proprietary device is designed for use in Automated Peritoneal Dialysis (APD) therapy, which continues to be the most frequently utilized home therapy for the treatment of end-stage renal disease (ESRD).
